A Dose Escalation Study of OMP-54F28 in Subjects With Solid Tumors
NCT01608867
·
clinicaltrials.gov ↗
PHASE1
Phase
COMPLETED
Status
26
Enrollment
INDUSTRY
Sponsor class
Conditions
Solid Tumors
Interventions
BIOLOGICAL:
OMP-54F28
Sponsor
OncoMed Pharmaceuticals, Inc.
Collaborators
[object Object]